SCHEMBL9779

SCHEMBL9779

COC(C)C(=O)NCC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.53
L3MBTL1 Q9Y468 1/20 0.51
ALDH1A1 P00352 1/20 0.49
EPHX1 P07099 3/20 0.49
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
MMP1 P03956 1/20 0.46
MMP2 P08253 1/20 0.46
MMP3 P08254 1/20 0.46
MMP9 P14780 1/20 0.46
MMP8 P22894 1/20 0.46
CA9 Q16790 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
CYP2D6 P10635 1/20 0.45
EPHX2 P34913 1/20 0.44
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14948950 0.85 TDP1 (0.52) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL16281010 0.83 TDP1 (0.51) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL17081330 0.82 TDP1 (0.50) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL13581 0.82 EPHX1 (0.55) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL19652274 0.82 EPHX1 (0.55) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL12026402 0.80 EPHX1 (0.52) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL3220227 0.79 EPHX1 (0.52) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL27770664 0.79 EPHX1 (0.52) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL3046964 0.76 TSHR (0.49) TDP1L3MBTL1ALDH1A1EPHX1CA12
SCHEMBL3224826 0.76 TSHR (0.49) TDP1L3MBTL1ALDH1A1EPHX1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9296698-B2 Amino heteroaryl compounds as beta-secretase modulators and methods of use AMGEN INC. (US) 2016-03-29 US disclosed
EP-2595995-B1 HERBICIDAL ISOXAZOLO[5,4-B]PYRIDINES BASF SE (DE) 2015-11-25 EP disclosed
US-20120329830-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use AMGEN INC. (US) 2012-12-27 US disclosed
EP-2504315-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE Amgen Inc. (US) 2012-10-03 EP disclosed
WO-2011063233-A1 AMINO HETEROARYL COMPOUNDS AS BETA-SECRETASE MODULATORS AND METHODS OF USE AMGEN INC. (US) 2011-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120329830-A1 Amino Heteroaryl Compounds as Beta-Secretase Modulators and Methods of Use BACE1, BACE2, APP TDP1 778/4885L3MBTL1 788/4885ALDH1A1 1846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.